CRL Annual CFI
-$563.15 M
+$44.77 M+7.36%
30 December 2023
Summary:
As of January 21, 2025, CRL annual cash flow from investing activities is -$563.15 million, with the most recent change of +$44.77 million (+7.36%) on December 30, 2023. During the last 3 years, it has risen by +$38.39 million (+6.38%). CRL annual CFI is now -9875.30% below its all-time high of $5.76 million, reached on December 25, 2010.CRL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly CFI
-$21.32 M
+$40.54 M+65.53%
28 September 2024
Summary:
As of January 21, 2025, CRL quarterly cash flow from investing activities is -$21.32 million, with the most recent change of +$40.54 million (+65.53%) on September 28, 2024. Over the past year, it has increased by +$217.05 million (+91.05%). CRL quarterly CFI is now -124.11% below its all-time high of $88.46 million, reached on September 30, 2006.CRL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL TTM CFI
-$407.35 M
+$58.23 M+12.51%
28 September 2024
Summary:
As of January 21, 2025, CRL TTM cash flow from investing activities is -$407.35 million, with the most recent change of +$58.23 million (+12.51%) on September 28, 2024. Over the past year, it has increased by +$155.80 million (+27.67%). CRL TTM CFI is now -7170.87% below its all-time high of $5.76 million, reached on December 25, 2010.CRL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.4% | +91.0% | +27.7% |
| 3 y3 years | +6.4% | +91.0% | +27.7% |
| 5 y5 years | +41.0% | +91.0% | +27.7% |
CRL Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +60.8% | -148.1% | +95.4% | -45.3% | +71.7% |
| 5 y | 5-year | at high | +60.8% | -148.1% | +97.8% | -45.3% | +73.5% |
| alltime | all time | -9875.3% | +60.8% | -124.1% | +97.8% | -7170.9% | +73.5% |
Charles River Laboratories International Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$21.32 M(-65.5%) | -$407.35 M(-12.5%) |
| June 2024 | - | -$61.87 M(-27.9%) | -$465.59 M(-3.1%) |
| Mar 2024 | - | -$85.79 M(-64.0%) | -$480.33 M(-14.7%) |
| Dec 2023 | -$563.15 M(-7.4%) | -$238.37 M(+199.6%) | -$563.15 M(+100.8%) |
| Sept 2023 | - | -$79.56 M(+3.8%) | -$280.40 M(-4.3%) |
| June 2023 | - | -$76.61 M(-54.6%) | -$293.03 M(-56.8%) |
| Mar 2023 | - | -$168.62 M(-479.9%) | -$678.53 M(+11.6%) |
| Dec 2022 | -$607.92 M(-57.7%) | $44.38 M(-148.1%) | -$607.92 M(-5.5%) |
| Sept 2022 | - | -$92.19 M(-80.1%) | -$643.00 M(-29.0%) |
| June 2022 | - | -$462.11 M(+371.5%) | -$905.86 M(-35.2%) |
| Mar 2022 | - | -$98.00 M(-1153.0%) | -$1.40 B(-2.8%) |
| Dec 2021 | -$1.44 B(+139.0%) | $9.31 M(-102.6%) | -$1.44 B(-6.4%) |
| Sept 2021 | - | -$355.05 M(-62.8%) | -$1.54 B(+22.7%) |
| June 2021 | - | -$954.19 M(+591.5%) | -$1.25 B(+284.0%) |
| Mar 2021 | - | -$138.00 M(+56.1%) | -$325.86 M(-45.8%) |
| Dec 2020 | -$601.54 M(-11.7%) | -$88.42 M(+24.9%) | -$601.54 M(+3.0%) |
| Sept 2020 | - | -$70.81 M(+147.4%) | -$583.99 M(+1.6%) |
| June 2020 | - | -$28.63 M(-93.1%) | -$574.58 M(-46.5%) |
| Mar 2020 | - | -$413.69 M(+483.7%) | -$1.07 B(+57.6%) |
| Dec 2019 | -$681.50 M(-28.6%) | -$70.87 M(+15.4%) | -$681.50 M(-0.0%) |
| Sept 2019 | - | -$61.39 M(-88.4%) | -$681.59 M(+4.3%) |
| June 2019 | - | -$528.42 M(+2438.9%) | -$653.21 M(-31.3%) |
| Mar 2019 | - | -$20.81 M(-70.7%) | -$951.15 M(-0.4%) |
| Dec 2018 | -$955.00 M(+1215.7%) | -$70.96 M(+114.9%) | -$955.00 M(+4.2%) |
| Sept 2018 | - | -$33.01 M(-96.0%) | -$916.87 M(-2.2%) |
| June 2018 | - | -$826.37 M(+3250.5%) | -$937.65 M(+524.1%) |
| Mar 2018 | - | -$24.66 M(-24.9%) | -$150.25 M(+107.0%) |
| Dec 2017 | -$72.59 M(-89.5%) | -$32.83 M(-39.0%) | -$72.59 M(-36.8%) |
| Sept 2017 | - | -$53.78 M(+38.0%) | -$114.76 M(+55.4%) |
| June 2017 | - | -$38.97 M(-173.5%) | -$73.87 M(-88.3%) |
| Mar 2017 | - | $53.00 M(-170.7%) | -$633.23 M(-8.6%) |
| Dec 2016 | -$692.67 M(+111.4%) | -$75.00 M(+481.7%) | -$692.67 M(-0.5%) |
| Sept 2016 | - | -$12.89 M(-97.8%) | -$696.31 M(-22.3%) |
| June 2016 | - | -$598.33 M(+9188.0%) | -$895.90 M(+178.4%) |
| Mar 2016 | - | -$6.44 M(-91.8%) | -$321.76 M(-1.8%) |
| Dec 2015 | -$327.62 M(+9.9%) | -$78.64 M(-63.0%) | -$327.62 M(-0.7%) |
| Sept 2015 | - | -$212.49 M(+778.2%) | -$329.78 M(+149.9%) |
| June 2015 | - | -$24.20 M(+96.8%) | -$131.98 M(-56.6%) |
| Mar 2015 | - | -$12.29 M(-84.8%) | -$303.77 M(+1.9%) |
| Dec 2014 | -$297.99 M(+302.4%) | -$80.80 M(+450.0%) | -$297.99 M(+25.8%) |
| Sept 2014 | - | -$14.69 M(-92.5%) | -$236.90 M(+0.1%) |
| June 2014 | - | -$195.99 M(+2910.1%) | -$236.56 M(+356.9%) |
| Mar 2014 | - | -$6.51 M(-67.0%) | -$51.78 M(-30.1%) |
| Dec 2013 | -$74.05 M(+34.7%) | -$19.71 M(+37.4%) | -$74.05 M(-0.1%) |
| Sept 2013 | - | -$14.35 M(+28.0%) | -$74.11 M(-14.2%) |
| June 2013 | - | -$11.21 M(-61.1%) | -$86.40 M(+7.3%) |
| Mar 2013 | - | -$28.78 M(+45.6%) | -$80.49 M(+46.4%) |
| Dec 2012 | -$54.99 M | -$19.77 M(-25.8%) | -$54.99 M(-8.1%) |
| Sept 2012 | - | -$26.64 M(+402.6%) | -$59.81 M(+60.2%) |
| June 2012 | - | -$5.30 M(+61.7%) | -$37.34 M(+36.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$3.28 M(-86.7%) | -$27.39 M(-25.3%) |
| Dec 2011 | -$36.65 M(-736.1%) | -$24.60 M(+489.8%) | -$36.65 M(+54.8%) |
| Sept 2011 | - | -$4.17 M(-189.5%) | -$23.67 M(-7.6%) |
| June 2011 | - | $4.66 M(-137.1%) | -$25.61 M(-40.2%) |
| Mar 2011 | - | -$12.54 M(+7.9%) | -$42.82 M(-843.3%) |
| Dec 2010 | $5.76 M(-102.8%) | -$11.62 M(+90.3%) | $5.76 M(-113.0%) |
| Sept 2010 | - | -$6.11 M(-51.4%) | -$44.28 M(+22.0%) |
| June 2010 | - | -$12.56 M(-134.8%) | -$36.30 M(-67.1%) |
| Mar 2010 | - | $36.05 M(-158.5%) | -$110.47 M(-47.1%) |
| Dec 2009 | -$208.82 M(-8.1%) | -$61.67 M(-3390.6%) | -$208.82 M(+6.0%) |
| Sept 2009 | - | $1.87 M(-102.2%) | -$197.03 M(-35.5%) |
| June 2009 | - | -$86.72 M(+39.2%) | -$305.54 M(+9.4%) |
| Mar 2009 | - | -$62.30 M(+24.9%) | -$279.23 M(+22.9%) |
| Dec 2008 | -$227.18 M(+13.1%) | -$49.88 M(-53.2%) | -$227.18 M(-7.4%) |
| Sept 2008 | - | -$106.64 M(+76.5%) | -$245.35 M(+37.5%) |
| June 2008 | - | -$60.41 M(+489.4%) | -$178.39 M(+15.2%) |
| Mar 2008 | - | -$10.25 M(-84.9%) | -$154.87 M(-22.9%) |
| Dec 2007 | -$200.78 M(+85.9%) | -$68.06 M(+71.6%) | -$200.78 M(-16.4%) |
| Sept 2007 | - | -$39.67 M(+7.5%) | -$240.27 M(+114.3%) |
| June 2007 | - | -$36.90 M(-34.3%) | -$112.14 M(-18.8%) |
| Mar 2007 | - | -$56.16 M(-47.8%) | -$138.13 M(+27.9%) |
| Dec 2006 | -$107.99 M(-5.3%) | -$107.54 M(-221.6%) | -$107.99 M(+177.2%) |
| Sept 2006 | - | $88.46 M(-240.7%) | -$38.95 M(-77.6%) |
| June 2006 | - | -$62.88 M(+141.6%) | -$173.83 M(+37.8%) |
| Mar 2006 | - | -$26.02 M(-32.4%) | -$126.14 M(+10.7%) |
| Dec 2005 | -$113.99 M(-81.0%) | -$38.50 M(-17.1%) | -$113.99 M(-82.1%) |
| Sept 2005 | - | -$46.42 M(+205.6%) | -$635.52 M(+6.2%) |
| June 2005 | - | -$15.19 M(+9.4%) | -$598.32 M(+1.2%) |
| Mar 2005 | - | -$13.88 M(-97.5%) | -$591.11 M(-1.5%) |
| Dec 2004 | -$599.97 M(+846.5%) | -$560.03 M(+5974.7%) | -$599.97 M(+939.6%) |
| Sept 2004 | - | -$9.22 M(+15.6%) | -$57.71 M(-16.5%) |
| June 2004 | - | -$7.97 M(-64.9%) | -$69.12 M(-1.5%) |
| Mar 2004 | - | -$22.75 M(+28.0%) | -$70.19 M(+10.7%) |
| Dec 2003 | -$63.39 M(-19.6%) | -$17.77 M(-13.8%) | -$63.39 M(-21.6%) |
| Sept 2003 | - | -$20.63 M(+128.1%) | -$80.84 M(+15.4%) |
| June 2003 | - | -$9.04 M(-43.3%) | -$70.04 M(-21.6%) |
| Mar 2003 | - | -$15.95 M(-54.7%) | -$89.30 M(+13.2%) |
| Dec 2002 | -$78.89 M(-14.2%) | -$35.23 M(+258.5%) | -$78.89 M(+32.5%) |
| Sept 2002 | - | -$9.83 M(-65.3%) | -$59.54 M(-4.8%) |
| June 2002 | - | -$28.30 M(+411.3%) | -$62.51 M(+50.0%) |
| Mar 2002 | - | -$5.54 M(-65.1%) | -$41.69 M(-54.6%) |
| Dec 2001 | -$91.92 M(+530.6%) | -$15.88 M(+24.0%) | -$91.92 M(+10.6%) |
| Sept 2001 | - | -$12.80 M(+71.3%) | -$83.08 M(+14.3%) |
| June 2001 | - | -$7.47 M(-86.6%) | -$72.70 M(+6.1%) |
| Mar 2001 | - | -$55.77 M(+692.6%) | -$68.55 M(+370.3%) |
| Dec 2000 | -$14.58 M(-57.3%) | -$7.04 M(+190.5%) | -$14.58 M(+93.3%) |
| Sept 2000 | - | -$2.42 M(-27.1%) | -$7.54 M(+47.3%) |
| June 2000 | - | -$3.32 M(+84.8%) | -$5.12 M(+184.8%) |
| Mar 2000 | - | -$1.80 M | -$1.80 M |
| Dec 1999 | -$34.17 M(+48.4%) | - | - |
| Dec 1998 | -$23.03 M | - | - |
FAQ
- What is Charles River Laboratories International annual cash flow from investing activities?
- What is the all time high annual CFI for Charles River Laboratories International?
- What is Charles River Laboratories International annual CFI year-on-year change?
- What is Charles River Laboratories International quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly CFI year-on-year change?
- What is Charles River Laboratories International TTM cash flow from investing activities?
- What is the all time high TTM CFI for Charles River Laboratories International?
- What is Charles River Laboratories International TTM CFI year-on-year change?
What is Charles River Laboratories International annual cash flow from investing activities?
The current annual CFI of CRL is -$563.15 M
What is the all time high annual CFI for Charles River Laboratories International?
Charles River Laboratories International all-time high annual cash flow from investing activities is $5.76 M
What is Charles River Laboratories International annual CFI year-on-year change?
Over the past year, CRL annual cash flow from investing activities has changed by +$44.77 M (+7.36%)
What is Charles River Laboratories International quarterly cash flow from investing activities?
The current quarterly CFI of CRL is -$21.32 M
What is the all time high quarterly CFI for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly cash flow from investing activities is $88.46 M
What is Charles River Laboratories International quarterly CFI year-on-year change?
Over the past year, CRL quarterly cash flow from investing activities has changed by +$217.05 M (+91.05%)
What is Charles River Laboratories International TTM cash flow from investing activities?
The current TTM CFI of CRL is -$407.35 M
What is the all time high TTM CFI for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM cash flow from investing activities is $5.76 M
What is Charles River Laboratories International TTM CFI year-on-year change?
Over the past year, CRL TTM cash flow from investing activities has changed by +$155.80 M (+27.67%)